Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions
Breast Cancer
What is the purpose of this trial?
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells.
PURPOSE: This phase II trial is studying how well tamoxifen citrate works in patients with metastatic or recurrent breast cancer.
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Eastern Cooperative Oncology Group
National Cancer Institute (NCI) - Dates:
- September 2010
- Last Updated:
- November 17, 2012
- Study HIC#:
- 1102007970
Clinicaltrials.gov ID: NCT01124695
For more information about this trial, contact:
Noelle Sowers
203-737-3472
noelle.sowers@yale.edu
Investigator
Erin Hofstatter, MD
Principal Investigator
